Navigation Links
Orexigen(R) Therapeutics Announces Fourth Quarter and Year Ended December 31, 2009 Financial Results
Date:3/9/2010

Year ended December 31, 2009

For the year ended December 31, 2009, Orexigen reported a net loss of $66.6 million, or $1.67 per share attributable to common stockholders, as compared to a net loss of $93.2 million, or $2.76 per share attributable to common stockholders, for 2008.  

Total operating expenses for the year ended December 31, 2009 were $65.6 million compared to $94.9 million for 2008.  The decreased operating expenses were due primarily to a decrease in research and development expenses of $31.8 million related to the completion of our Contrave Phase 3 clinical trials and completion of our Phase 2 clinical trial for Empatic, offset partly by an increase in general and administrative costs of $2.5 million due principally to increases in salaries and personnel related costs, medical affairs expense, recruiting expense and public relations costs.


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
2. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
3. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
4. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
5. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
6. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
7. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
8. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
9. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
10. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
11. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , 21. November 2014 Michael ... sich am Morgen des 14. Februar 2014 zugetragen hat. ... wohl kaum vergessen. Video - http://youtu.be/5cVoMCe0uiE ... ich dabei war, mein morgendliches Training zu machen", erzählt ... zu der Zeit begeisterte Anhänger der CrossFit-Trainingsmethode. ...
(Date:11/21/2014)...   Coqui RadioPharmaceuticals Corp. , a medical isotope ... of Molybdenum-99 (Mo-99), is proud to announce it has ... design its Medical Isotope Production Facility (MIPF) in ... isotope of Technetium-99, which is used in 80 percent ... legislation making it a national priority to produce Mo-99, ...
(Date:11/21/2014)...   Wellcentive , the industry leader in ... announced today being named one of the four ... .  Sponsored by Intel, the world leader in ... recognizes companies developing leading-edge technology and unique approaches ... Wellcentive,s Mason Beard , senior ...
Breaking Medicine Technology:Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3Coqui RadioPharmaceuticals Inks Deal With INVAP 2Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3
... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) today announced that the following presentations,will ... formerly XYOTAX(TM)),at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting,May 30 through ... Poster # ... (Abstract#) Sat., ...
... First and Only Treatment for Hunter Syndrome Now Approved in ... ... Worldwide, BASINGSTOKE, England and CAMBRIDGE, Massachusetts, May ... company, announced that ELAPRASE(R),(idursulfase), a human enzyme replacement therapy for ...
Cached Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 2Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 2Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 4Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 5
(Date:11/21/2014)... Launched today on the iTunes App Store, ... care coordination tool designed to make tracking and sharing ... for family members and caregivers (e.g. physicians home care ... caregiver or home health aide providing care for a ... records, goals, schedules, and even final plans in one ...
(Date:11/21/2014)... OXNARD, CA (PRWEB) November 21, 2014 For ... worth the multiple office visits and months of recovery from ... mouth reconstruction – even at the cost of their youthful ... the Anacapa Dental Art Institute in Oxnard and Woodland Hills, ... teeth in one visit, even in instances where the patient’s ...
(Date:11/21/2014)... 21, 2014 Even with years of experience ... learn and room for growth, participating in two recent events ... Farm’s National Convention, a networking event with the leaders of ... bringing back the latest and greatest in insurance news and ... Kirk and his team (Stacy, Anthony, Reina and Jacob) as ...
(Date:11/21/2014)... According to a National Highway Transportation ... 2014, the inflating system found in certain airbags produced ... The force of inflation may cause the metal canister ... may pierce the airbag’s fabric and potentially cause injuries ... to a Bloomberg Business Week article on ...
(Date:11/21/2014)... Salamon HealthDay Reporter ... intellectually challenging tasks may help preserve thinking skills and ... The researchers compared IQ scores obtained around age ... memory and reasoning scores around age 70. The scientists ... to retain sharper thinking even years after retirement. ...
Breaking Medicine News(10 mins):Health News:Comprehensive Senior Care Application Launched on Apple App Store 2Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 2Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 3Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 4Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 5Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3Health News:Could Your Job Help Preserve Your Aging Brain? 2Health News:Could Your Job Help Preserve Your Aging Brain? 3
... Scientists at the leading Swedish medical university Karolinska Institutet ... maintain an appropriate number of ATP sensing ion channel ... in the latest number of Cell Metabolism, explains how ... within the normal range and thereby avoid the development ...
... Firm Ranked Among Inc. ... -, NEW YORK and SAN FRANCISCO, Sept. 5 ... today announced 10 recent new hires to work on several ... Chicago offices. The Company also announced that the 2007 ...
... to Manage ... Menopausal Symptoms, WASHINGTON, Sept. 5 Results from ... since the,release of initial findings from the Women,s Health Initiative (WHI) leave,no ... both,physicians and patients regarding the results of the WHI study. The online,survey ...
... 5 With nationwide recalls of,led-laced baby bibs, led is a ... do with all of this lead information? Now what do I,buy? ... the available bibs?" Bibs,are a necessity; used 5 times everyday for ... can feel safe feeding their children,with the help of a Crumb ...
... lead to tough choices for older Americans, researchers find ... in Medicare plans that charge higher co-pays for brand ... prescriptions than their peers who have a flat co-pay ... The data highlights a tough decision for older Americans: ...
... Doctors Grow as MedHelp Focuses on Answering More ... Consumer Health Questions ... online,health community connecting people to medical experts, information and,shared experiences, ... M.D. and Stephen Ryu, M.D. have joined their,premier roster of ...
Cached Medicine News:Health News:Scientists explain how insulin secreting cells maintain their glucose sensitivity 2Health News:WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business 2Health News:One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High 2Health News:One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High 3Health News:One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High 4Health News:Mother and Daughter Create Lead-Free/Safe Bibs and Solve Messy Mealtime Problems 2Health News:High Co-Pays Cause Seniors to Go Without Meds 2Health News:MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community 2Health News:MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community 3
... surgery, and the accompanying need for patient ... graft be developed. Grafts must not only ... available in varying sizes and configurations for ... long been the prosthetic of choice among ...
... GORE-TEX Vascular Grafts have met the challenges ... over 25 years. Recognized for exceptional performance ... of renowned surgeons worldwide. These grafts require ... of infection, and assure utmost thrombectomy safety. ...
... Vascular Grafts have met the challenges of ... 25 years. Recognized for exceptional performance and ... renowned surgeons worldwide. These grafts require no ... infection, and assure utmost thrombectomy safety. Gore ...
... Graft, the newest vascular graft offering from ... in vascular surgical products for more than ... kinking and compression problems that can ... provides all of the benefits of a ...
Medicine Products: